Protagenic Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $25 | $0 | $3 |
Gross Profit | 25 | -12 | -12 | |
EBITDA | -1,541 | -639 | -1,593 | -1,711 |
EBIT | -1,553 | -652 | -1,606 | -1,724 |
Net Income | -1,553 | -640 | -1,606 | -1,724 |
Net Change In Cash | 0 | 25 | 0 | 3 |
Free Cash Flow | -819 | -185 | -1,551 | -1,659 |
Cash | 1,838 | 1,055 | 924 | 831 |
Basic Shares | 4,714 | 4,529 | 4,443 | 4,435 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -28 | |||
EBITDA | -5,700 | -4,498 | -3,418 | -4,140 |
EBIT | -4,526 | -3,418 | -4,140 | |
Net Income | -5,525 | -5,000 | -3,601 | -4,986 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,216 | -3,853 | -1,995 | -2,798 |
Cash | 1,838 | 1,287 | 215 | 541 |
Basic Shares | 4,899 | 4,344 | 4,317 | 3,685 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.23 |
2024-09-30 | -$0.14 |
2024-06-30 | -$0.36 |
2024-03-31 | -$0.38 |
